Trials / Unknown
UnknownNCT03939845
A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi
A Prospective, Randomized, Multicenter Study of Comparison of Transarterial Chemoembolization (TACE) Combination With and Without External- Beam Radiotherapy (EBRT) for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The 1-year and 2-year overall survival rate (OS), local control rate (FFLP), disease-free progression time (PFS), and side effects were compared in patients with hepatocellular carcinoma limited to intrahepatic unresectable hepatocellular carcinoma with portal venous thrombosis combined with or without external radiotherapy, providing a basis for the development of relevant guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | RT | external- beam radiotherapy (EBRT) |
| PROCEDURE | TACE | transarterial chemoembolization (TACE) |
Timeline
- Start date
- 2019-04-23
- Primary completion
- 2021-04-23
- Completion
- 2022-04-23
- First posted
- 2019-05-07
- Last updated
- 2019-05-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03939845. Inclusion in this directory is not an endorsement.